Your browser doesn't support javascript.
loading
Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond.
Gadaleta-Caldarola, Gennaro; Divella, Rosa; Mazzocca, Antonio; Infusino, Stefania; Ferraro, Emanuela; Filippelli, Gianfranco; Daniele, Antonella; Sabbà, Carlo; Abbate, Ines; Brandi, Mario.
Afiliação
  • Gadaleta-Caldarola G; Division of Oncology, "Mons. R Dimiccoli" Hospital, Viale Ippocrate, 15, 76121 Barletta (BT), Asl BAT, Italy.
  • Divella R; Clinical Pathology Laboratory, National Cancer Research Centre, Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco, 65, 70100 Bari, Italy.
  • Mazzocca A; Interdisciplinary Department of Medicine, University of Bari School of Medicine, Piazza G. Cesare, 11, 70124 Bari, Italy.
  • Infusino S; National Institute for Digestive Diseases, IRCCS "Saverio De Bellis", Via Turi 27, 70013, Castellana Grotte, Bari, Italy.
  • Ferraro E; Division of Oncology, "S Francesco di Paola" Hospital, Via Promintesta, 1, 87027 Paola (CS), ASP, Italy.
  • Filippelli G; Department of Internal Medicine & Clinical Specialties, University of Rome "La Sapienza", Policlinico Umberto I, Viale del Policlinico, 155, 00161 Roma, Italy.
  • Daniele A; Division of Oncology, "S Francesco di Paola" Hospital, Via Promintesta, 1, 87027 Paola (CS), ASP, Italy.
  • Sabbà C; Clinical Pathology Laboratory, National Cancer Research Centre, Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco, 65, 70100 Bari, Italy.
  • Abbate I; Interdisciplinary Department of Medicine, University of Bari School of Medicine, Piazza G. Cesare, 11, 70124 Bari, Italy.
  • Brandi M; Clinical Pathology Laboratory, National Cancer Research Centre, Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco, 65, 70100 Bari, Italy.
Future Oncol ; 11(16): 2263-6, 2015.
Article em En | MEDLINE | ID: mdl-26260805

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Niacinamida / Carcinoma Hepatocelular / Inibidores de Proteínas Quinases / Neoplasias Hepáticas / Antineoplásicos Limite: Humans Idioma: En Revista: Future Oncol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Niacinamida / Carcinoma Hepatocelular / Inibidores de Proteínas Quinases / Neoplasias Hepáticas / Antineoplásicos Limite: Humans Idioma: En Revista: Future Oncol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Itália